Review reveals the synthesis and biological effects of quinazolines in medicinal chemistry, highlighting anticancer and antibacterial potential.
This review covers article and patent data obtained mostly within the period 2013−2024 on the synthesis and biological activity of quinazolines [a]-annelated by five-membered heterocycles. Pyrrolo-, (iso)indolo-, pyrazolo-, indazolo-, (benz)imidazo-, (benz)thiazolo- and triazolo- [a]quinazoline systems have shown multiple potential activities against numerous targets. We highlight that most research efforts are directed to design of anticancer, antibacterial, anti-inflammatory and other agents of azolo[a]quinazoline nature. This review emphases both on the medicinal chemistry aspects of pyrrolo[a]-, (iso)indolo[a]- and azolo[a]quinazolines and comprehensive synthetic strategies of quinazolines annelated at N(1)–C(2) bond in the perspective of drug development and discovery.
No takes yet. Share an insight, caveat, or question.
Lipunova et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: